Komori
Mitsui Chemicals (4183) · TargetPerformance continues to diverge across the growth businessesLatest Earnings presentation (2026-08-05): "Advanced"

Expanding earnings in growth-driving businesses

First written in FY2016. 9 of 32 entries say "Advanced", first in FY2017. Latest entry: 2026-08-05.

32entries
11years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2019-Q1 – FY2021OtherFY2022 – FY2026-H12016: 120162017: 220172018: 420182019: 420192020: 420202021: 420212022: 420222023: 320232024: 220242025: 120252026: 32026
Same theme, other companies
Business Creation through the Selection of Priority Growth and Development AreasA theme 111 companies write about · 0 as a headwind · 117 as a tailwind

64 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 111 companies compared. The sentences above are computed from all 111.
Full recordFilings, disclosures and news, newest first
  1. 2026-08-05AdvancedEarnings presentation

    「Although the growth areas were affected mainly by the situation in the Middle East in Mobility Solutions, sales volumes in Life & Healthcare Solutions and ICT Solutions remained firm, and foreign exchange gains from the weaker yen also contributed. As a result, profit increased by ¥2.9 billion, or 10%, year on year to ¥32.7 billion.」

    Core operating profit in the growth areas increased by ¥2.9 billion year on year. Mobility Solutions, however, was affected by the situation in the Middle East.
  2. FY2026Performance continues to diverge across the growth businessesAnnual report

    「The Life & Healthcare Solutions segment posted higher revenue and higher profit. The Mobility Solutions segment posted lower revenue and lower profit. The ICT Solutions segment posted higher revenue and higher profit.」

    In the new portfolio, Life & Healthcare and ICT posted higher revenue and higher profit, while Mobility posted lower revenue and lower profit due to U.S. tariffs, semiconductor supply shortages, reduced OEM production, and other factors. Performance continued to diverge across the businesses.
  3. 2026-05-13AdvancedEarnings presentation

    「In the growth areas, Life & Healthcare Solutions remained firm, led by vision care and crop protection products; Mobility Solutions increased EBITDA despite higher depreciation and amortization expenses from capacity expansion; and ICT Solutions is expected to generate profit of ¥130.0 billion, up ¥7.9 billion, or 6%, year on year, due to higher sales volumes accompanying growing demand in advanced fields.」

    The company presented a forecast for core operating profit in the growth areas to increase from the FY2025 result of ¥122.1 billion to ¥130.0 billion in the FY2026 forecast.
  4. FY2026-H1The new portfolio diverged between lower revenue and higher or lower profitAnnual report

    「(Life & Healthcare Solutions) Segment revenue was ¥115.3 billion, down ¥200 million from the previous interim consolidated accounting period. Core operating profit was ¥13.0 billion, down ¥2.3 billion, despite firm sales of vision-care products and agricultural chemicals, due to the impact of the shutdown of production equipment at the Omuta Plant. As a result, the segment as a whole posted lower revenue and lower profit. (Mobility Solutions) Segment revenue was ¥258.2 billion, down ¥18.6 billion from the previous interim consolidated accounting period due to the transfer of shares in a subsidiary. Core operating profit was ¥26.0 billion, down ¥2.4 billion, as deteriorating terms of trade due to the impact of U.S. tariffs, foreign exchange effects, and other factors outweighed firm sales of elastomers. As a result, the segment as a whole posted lower revenue and lower profit. (ICT Solutions) Segment revenue was ¥137.0 billion, down ¥2.8 billion from the previous interim consolidated accounting period due to the transfer of shares in a subsidiary. Core operating profit was ¥17.8 billion, up ¥5.0 billion, mainly because sales of semiconductors, optical materials, and ICT films and sheets remained firm. As a result, the segment as a whole posted lower revenue and higher profit.」

    Life & Healthcare Solutions and Mobility Solutions posted lower revenue and lower profit, ICT Solutions posted lower revenue but higher profit, and Basic & Green Materials posted lower revenue and a widening loss. Performance continued to diverge across the businesses.
  5. FY2025-H1The new portfolio diverged between higher revenue and higher or lower profitAnnual report

    「The Life & Healthcare Solutions segment posted higher revenue and higher profit. The Mobility Solutions segment posted higher revenue and higher profit. The ICT Solutions segment posted lower revenue and lower profit. The Basic & Green Materials segment posted higher revenue and an improvement in its core operating loss.」

    Life & Healthcare and Mobility posted higher revenue and higher profit, ICT posted lower revenue and lower profit, and Basic & Green Materials posted higher revenue but remained loss-making. Performance continued to diverge across the businesses.
  6. FY2024-Q3The new portfolio diverged between higher revenue and higher or lower profitAnnual report

    「Core operating profit was ¥72.4 billion, down ¥37.9 billion, or 34.4%, from the same quarter of the previous year. This was due mainly to lower sales volumes resulting from weak demand and lower equity-method investment gains.」

    Life & Healthcare Solutions posted higher revenue and lower profit, Mobility Solutions posted higher revenue and higher profit, ICT Solutions posted lower revenue and lower profit, and Basic & Green Materials posted lower revenue and a loss. Performance continued to diverge within the new 4-business portfolio.
  7. FY2024-Q2The new portfolio diverged between lower revenue and higher or lower profitAnnual report

    「(Life & Healthcare Solutions) Segment revenue was ¥119.1 billion, down ¥3.0 billion from the same quarter of the previous year, accounting for 14% of total revenue. Core operating profit was ¥11.2 billion, down ¥2.6 billion from the same quarter of the previous year, mainly because sales of vision-care materials remained weak. As a result, the segment as a whole posted lower revenue and lower profit. (Mobility Solutions) Segment revenue was ¥261.3 billion, up ¥5.9 billion from the same quarter of the previous year, accounting for 32% of total revenue. Core operating profit was ¥26.9 billion, up ¥3.5 billion from the same quarter of the previous year, mainly due to improved terms of trade resulting from price revisions and foreign exchange effects. As a result, the segment as a whole posted higher revenue and higher profit. (ICT Solutions) Segment revenue was ¥113.4 billion, down ¥4.8 billion from the same quarter of the previous year, accounting for 14% of total revenue. Core operating profit was ¥11.4 billion, down ¥3.6 billion from the same quarter of the previous year, as improved terms of trade due to foreign exchange effects and other factors was outweighed mainly by the impact of slowing semiconductor demand. As a result, the segment as a whole posted lower revenue and lower profit. (Basic & Green Materials) Segment revenue was ¥322.1 billion, down ¥126.2 billion from the same quarter of the previous year, accounting for 39% of total revenue. Core operating loss was ¥7.1 billion, a deterioration of ¥34.4 billion from the same quarter of the previous year, due mainly to lower sales volumes resulting from slowing demand and reduced inventory valuation gains. As a result, the segment as a whole posted lower revenue and lower profit.」

    In the new 4-business portfolio, Mobility Solutions posted higher revenue and higher profit, while Life & Healthcare Solutions, ICT Solutions, and Basic & Green Materials posted lower revenue and lower profit or losses. Performance continued to diverge.
  8. FY2024-Q1Performance diverged within the new portfolio due to weak demandAnnual report

    「Core operating profit was ¥20.9 billion, down ¥23.7 billion, or 53.1%, from the same quarter of the previous year. This was due mainly to lower sales volumes resulting from weak demand and lower equity-method investment gains.」

    Core operating profit declined substantially across the growth and new-business portfolio as a whole. Mobility posted higher profit, while Life & Healthcare, ICT, and Basic & Green Materials posted lower profit or losses, and performance continued to diverge.
  9. FY2023-Q3The new portfolio diverged between higher revenue and higher or lower profitAnnual report

    「(Life & Healthcare Solutions) Segment revenue was ¥186.8 billion, up ¥27.9 billion from the same quarter of the previous year, accounting for 13% of total revenue. Core operating profit was ¥21.6 billion, up ¥3.3 billion from the same quarter of the previous year, mainly because sales of agricultural chemicals remained firm. As a result, the segment as a whole posted higher revenue and higher profit. (Mobility Solutions) Segment revenue was ¥390.8 billion, up ¥79.4 billion from the same quarter of the previous year, accounting for 27% of total revenue. Core operating profit was ¥38.9 billion, up ¥14.9 billion from the same quarter of the previous year, mainly due to improved terms of trade resulting from price revisions and foreign exchange effects. As a result, the segment as a whole posted higher revenue and higher profit. (ICT Solutions) Segment revenue was ¥179.6 billion, up ¥24.3 billion from the same quarter of the previous year, accounting for 13% of total revenue. Core operating profit was ¥23.0 billion, down ¥2.2 billion from the same quarter of the previous year, as improved terms of trade due to foreign exchange effects and other factors was outweighed mainly by the impact of slowing semiconductor demand. As a result, the segment as a whole posted higher revenue and lower profit. (Basic & Green Materials) Segment revenue was ¥660.5 billion, up ¥128.9 billion from the same quarter of the previous year, accounting for 46% of total revenue. Core operating profit was ¥29.8 billion, down ¥37.7 billion from the same quarter of the previous year, mainly due to declines in overseas market prices for bisphenol A and other products, as well as a reduction in inventory valuation gains resulting from lower prices of naphtha and other raw materials. As a result, the segment as a whole posted higher revenue and lower profit.」

    Life & Healthcare Solutions and Mobility Solutions posted higher revenue and higher profit, while ICT Solutions and Basic & Green Materials posted higher revenue and lower profit. Performance continued to diverge within the growth and new-business portfolio.
  10. FY2023-Q2The new portfolio diverged between higher revenue and higher or lower profitAnnual report

    「(Life & Healthcare Solutions) Segment revenue was ¥122.1 billion, up ¥19.3 billion from the same quarter of the previous year, accounting for 13% of total revenue. Core operating profit was ¥13.8 billion, up ¥2.1 billion from the same quarter of the previous year, mainly because sales of vision-care materials and agricultural chemicals remained firm. (Mobility Solutions) Segment revenue was ¥255.4 billion, up ¥56.0 billion from the same quarter of the previous year, accounting for 27% of total revenue. Core operating profit was ¥23.4 billion, up ¥7.1 billion from the same quarter of the previous year, mainly due to improved terms of trade resulting from price revisions and foreign exchange effects. (ICT Solutions) Segment revenue was ¥118.2 billion, up ¥16.5 billion from the same quarter of the previous year, accounting for 12% of total revenue. Core operating profit was ¥15.0 billion, down ¥1.7 billion from the same quarter of the previous year, as improved terms of trade due to foreign exchange effects and other factors was outweighed mainly by the impact of slowing semiconductor demand. (Basic & Green Materials) Segment revenue was ¥448.3 billion, up ¥113.8 billion from the same quarter of the previous year, accounting for 47% of total revenue. Core operating profit was ¥27.3 billion, down ¥22.3 billion from the same quarter of the previous year, mainly due to declines in overseas market prices for bisphenol A and other products.」

    In the new 4-business portfolio, Life & Healthcare Solutions and Mobility Solutions posted higher revenue and higher profit, while ICT Solutions and Basic & Green Materials posted higher revenue and lower profit.
  11. FY2023-Q1The new portfolio also diverged between higher revenue and lower profit, among other outcomesAnnual report

    「Segment revenue was ¥58.7 billion, up ¥6.4 billion from the same quarter of the previous year, accounting for 12% of total revenue. Core operating profit was ¥6.2 billion, down ¥200 million from the same quarter of the previous year, as deteriorating terms of trade due to higher raw material prices for nonwoven fabrics outweighed firm sales of vision-care materials and agricultural chemicals. As a result, the segment as a whole posted higher revenue and lower profit. Segment revenue was ¥120.6 billion, up ¥19.7 billion from the same quarter of the previous year, accounting for 25% of total revenue. Core operating profit was ¥9.5 billion, down ¥100 million from the same quarter of the previous year, as lower sales due to reduced automotive production and other factors outweighed improved terms of trade resulting mainly from price revisions and foreign exchange effects. As a result, the segment as a whole posted higher revenue and lower profit.」

    Both Life & Healthcare Solutions and Mobility Solutions posted higher revenue and lower profit, and performance in the growth businesses continued to diverge by factor.
  12. FY2022Growth businesses posted higher revenue, but Healthcare posted lower profitAnnual report

    「In the Mobility business, the automotive industry is generating increasingly diverse needs, including improved fuel efficiency, a shift toward electrification, lighter weight, and greater comfort.」

    In fiscal 2021, core operating profit increased to ¥49.0 billion for Mobility and ¥26.6 billion for Food & Packaging, while Healthcare posted core operating profit of ¥19.8 billion, down ¥100 million due to deteriorating terms of trade caused by higher raw material prices. Performance gaps remained among the growth businesses.
  13. FY2022-Q3AdvancedAnnual report

    「Core operating profit was ¥35.9 billion, up ¥16.4 billion from the same quarter of the previous year, mainly due to the recovery in global automotive production and other factors. Core operating profit was ¥16.6 billion, up ¥1.8 billion from the same quarter of the previous year, mainly because sales of vision-care materials remained firm. Core operating profit was ¥19.9 billion, up ¥4.7 billion from the same quarter of the previous year, mainly because sales of coatings, functional materials, and functional films and sheets remained firm.」

    All 3 growth businesses, Mobility, Healthcare, and Food & Packaging, posted higher revenue and higher profit. Core operating profit was ¥35.9 billion for Mobility, ¥16.6 billion for Healthcare, and ¥19.9 billion for Food & Packaging.
  14. FY2022-Q2AdvancedAnnual report

    「Core operating profit was ¥24.1 billion, up ¥15.9 billion from the same quarter of the previous year, mainly due to the recovery in global automotive production and other factors. Core operating profit was ¥10.9 billion, up ¥3.7 billion from the same quarter of the previous year, mainly because sales of vision-care materials remained firm. Core operating profit was ¥12.7 billion, up ¥3.2 billion from the same quarter of the previous year, mainly because sales of coatings, functional materials, and functional films and sheets remained firm.」

    All 3 growth businesses, Mobility, Healthcare, and Food & Packaging, posted higher revenue and higher profit. Core operating profit was ¥24.1 billion for Mobility, ¥10.9 billion for Healthcare, and ¥12.7 billion for Food & Packaging.
  15. FY2022-Q1AdvancedAnnual report

    「Core operating profit was ¥13.4 billion, up ¥11.1 billion from the same quarter of the previous year, mainly due to the recovery in global automotive production and other factors. Core operating profit was ¥6.0 billion, up ¥4.6 billion from the same quarter of the previous year, mainly because sales of vision-care materials remained firm. Core operating profit was ¥7.0 billion, up ¥2.6 billion from the same quarter of the previous year, mainly because sales of agricultural chemicals, coatings, and functional materials remained firm.」

    All 3 growth businesses, Mobility, Healthcare, and Food & Packaging, posted higher revenue and higher profit year on year. The quarter showed a recovery across all businesses, replacing the previous divergence in performance among the businesses.
  16. FY2021Growth businesses diverged between recovery and higher or lower profitAnnual report

    「In the Mobility business, the automotive industry is generating increasingly diverse needs, including improved fuel efficiency, a shift toward electrification, lighter weight, and greater comfort.」

    Mobility posted lower revenue and lower profit, with revenue of ¥315.5 billion and core operating profit of ¥30.2 billion. Healthcare posted higher revenue and higher profit, while Food & Packaging posted lower revenue and higher profit. Performance continued to diverge across the 3 growth businesses.
  17. FY2021-Q3Divergence continued across the 3 growth businesses between lower revenue and higher or lower profitAnnual report

    「Segment revenue was ¥220.8 billion, down ¥56.8 billion from the same quarter of the previous year, accounting for 26% of total revenue. Core operating profit was ¥19.5 billion, down ¥13.5 billion from the same quarter of the previous year, mainly due to slowing demand from the automotive industry and other factors. As a result, the segment as a whole posted lower revenue and lower profit. Segment revenue was ¥105.7 billion, down ¥1.2 billion from the same quarter of the previous year, accounting for 12% of total revenue. Core operating profit was ¥14.8 billion, up ¥5.3 billion from the same quarter of the previous year, mainly because sales of nonwoven fabrics remained firm. As a result, the segment as a whole posted lower revenue and higher profit. Segment revenue was ¥139.3 billion, down ¥5.6 billion from the same quarter of the previous year, accounting for 16% of total revenue. Core operating profit was ¥15.2 billion, up ¥3.6 billion from the same quarter of the previous year, mainly because sales of agricultural chemicals remained firm. As a result, the segment as a whole posted lower revenue and higher profit.」

    Mobility posted lower revenue and lower profit due to slowing demand from the automotive industry, while Healthcare, driven by nonwoven fabrics, and Food & Packaging, driven by firm sales of agricultural chemicals, posted lower revenue and higher profit. Performance continued to diverge across the businesses.
  18. FY2021-Q2The 3 growth businesses diverged between lower revenue and higher or lower profitAnnual report

    「Segment revenue was ¥132.0 billion, down ¥55.4 billion from the same quarter of the previous year, accounting for 25% of total revenue. Core operating profit was ¥8.2 billion, down ¥14.3 billion from the same quarter of the previous year, mainly due to slowing demand from the automotive industry and other factors. As a result, the segment as a whole posted lower revenue and lower profit. Segment revenue was ¥66.0 billion, down ¥3.8 billion from the same quarter of the previous year, accounting for 12% of total revenue. Core operating profit was ¥7.2 billion, up ¥1.3 billion from the same quarter of the previous year, mainly because sales of nonwoven fabrics remained firm. As a result, the segment as a whole posted lower revenue and higher profit. Segment revenue was ¥89.6 billion, down ¥7.0 billion from the same quarter of the previous year, accounting for 17% of total revenue. Core operating profit was ¥9.5 billion, up ¥1.7 billion from the same quarter of the previous year, mainly because sales of agricultural chemicals remained firm. As a result, the segment as a whole posted lower revenue and higher profit.」

    Mobility posted lower revenue and lower profit due to slowing demand from the automotive industry, while Healthcare, driven by nonwoven fabrics, and Food & Packaging, driven by firm sales of agricultural chemicals, posted lower revenue and higher profit. Performance continued to diverge across the growth businesses.
  19. FY2021-Q1Performance continues to diverge across the growth businessesAnnual report

    「Core operating profit was ¥2.3 billion, down ¥9.4 billion from the same quarter of the previous year, mainly due to slowing demand from the automotive industry and other factors. Core operating profit was ¥1.4 billion, down ¥2.3 billion from the same quarter of the previous year, mainly due to lower sales, despite lower fixed costs. Core operating profit was ¥4.4 billion, up ¥1.3 billion from the same quarter of the previous year, mainly because sales remained firm.」

    Mobility and Healthcare posted lower revenue and lower profit, while Food & Packaging posted higher profit on firm sales, and performance continued to diverge across the growth businesses.
  20. FY2020Performance continues to diverge across the growth businessesAnnual report

    「In the Mobility business, new needs such as weight reduction, electrification, and greater comfort are expanding in the automotive and ICT (information and communications technology) industries.」

    The company continues to prioritize the 3 growth businesses. In terms of results, Mobility posted lower revenue and lower profit, while Healthcare and Food & Packaging posted lower revenue and higher profit, with performance continuing to diverge across the businesses.
  21. FY2020-Q3Performance continues to diverge across the growth businessesAnnual report

    「Operating profit was ¥29.4 billion, down ¥2.1 billion from the same quarter of the previous year, mainly due to the impact of fixed costs associated with inventory and other factors. As a result, the segment as a whole posted lower revenue and lower profit. Operating profit was ¥9.8 billion, up ¥100 million from the same quarter of the previous year, as higher sales volumes more than offset higher fixed costs. As a result, the segment as a whole posted lower revenue and higher profit. Operating profit was ¥11.8 billion, broadly in line with the same quarter of the previous year, as improved terms of trade offset lower sales volumes and other factors. As a result, the segment as a whole posted lower revenue and profit broadly in line with the same quarter of the previous year.」

    Mobility posted lower revenue and lower profit, Healthcare posted lower revenue and higher profit, and Food & Packaging posted lower revenue with profit broadly unchanged. Performance continued to diverge across the 3 growth businesses.
  22. FY2020-Q2All 3 growth businesses posted lower revenue and lower profitAnnual report

    「Operating profit was ¥19.8 billion, down ¥300 million from the same quarter of the previous year, mainly due to the impact of higher fixed costs and other factors. Operating profit was ¥6.0 billion, down ¥300 million from the same quarter of the previous year, despite improved terms of trade, mainly due to higher fixed costs and other factors. Operating profit was ¥7.9 billion, down ¥900 million from the same quarter of the previous year, despite improved terms of trade and other factors, due to lower sales volumes.」

    All 3 growth businesses, Mobility, Healthcare, and Food & Packaging, posted lower revenue and lower profit, marking a shift from divergence within the growth businesses to an overall decline in profit.
  23. FY2020-Q1Performance continues to diverge across the growth businessesAnnual report

    「Operating profit was ¥10.1 billion, down ¥700 million from the same quarter of the previous year, mainly due to the impact of higher fixed costs and other factors.」

    Mobility posted lower profit, while Healthcare posted higher profit on improved terms of trade and other factors. Food & Packaging was broadly in line with the same period of the previous year, and performance continued to diverge across the 3 growth businesses.
  24. FY2019Performance continues to diverge across the 3 growth businessesAnnual report

    「Revenue in the Mobility segment increased by ¥64.4 billion from the previous fiscal year to ¥395.4 billion, accounting for 27% of total revenue. Operating profit increased by ¥0.4 billion to ¥42.7 billion, supported by higher sales volumes and other factors despite the impact of higher raw material prices and increased fixed costs.」

    Mobility and Healthcare posted higher profit, while Food & Packaging posted a ¥2.1 billion decline due to lower sales volumes, higher raw material prices and increased fixed costs, and performance continued to diverge across the growth businesses.
  25. FY2019-Q3Performance diverges across the growth businessesAnnual report

    「Revenue in this segment increased by ¥59.7 billion from the same period of the previous year to ¥294.5 billion, accounting for 26% of total revenue. Although sales volumes increased, operating profit fell ¥1.4 billion to ¥31.5 billion due to higher raw material prices and increased fixed costs.」

    Mobility posted lower profit despite higher sales volumes. Healthcare posted operating profit of ¥9.7 billion, up ¥1.8 billion year on year, while Food & Packaging posted ¥11.8 billion, down ¥2.7 billion, and performance continued to diverge across the growth businesses.
  26. FY2019-Q2Performance diverges across the growth businessesAnnual report

    「Revenue in this segment increased by ¥41.8 billion from the same period of the previous year to ¥195.2 billion, accounting for 27% of total revenue. Although sales volumes increased, operating profit fell ¥1.9 billion to ¥20.1 billion due to higher raw material prices and increased fixed costs.」

    Mobility posted lower profit despite higher sales volumes due to higher raw material prices and increased fixed costs. Healthcare posted operating profit of ¥6.3 billion, up ¥1.5 billion year on year, while Food & Packaging posted ¥8.8 billion, down ¥1.3 billion, resulting in divergent performance across the growth businesses.
  27. FY2019-Q1Performance diverges across the growth businessesAnnual report

    「Operating profit increased by ¥0.7 billion from the same period of the previous year to ¥3.6 billion, supported by generally firm sales despite the impact of higher raw material prices.」

    Healthcare posted operating profit of ¥3.6 billion, up ¥0.7 billion year on year, on firm sales. Mobility declined by ¥0.7 billion and Food & Packaging by ¥1.3 billion, resulting in divergent performance across the growth businesses.
  28. FY2018AdvancedAnnual report

    「Revenue in the Mobility segment increased by ¥37.7 billion from the previous fiscal year to ¥331.0 billion, accounting for 25% of total revenue. Operating profit increased by ¥1.6 billion to ¥42.3 billion, due to higher sales volumes and improved terms of trade, among other factors.」

    Within the growth businesses, Mobility posted operating profit of ¥42.3 billion on higher sales volumes and other factors. Healthcare also increased operating profit to ¥10.8 billion, while Food & Packaging posted ¥19.9 billion due to higher raw material prices and other factors.
  29. FY2018-Q3AdvancedAnnual report

    「Operating profit increased by ¥1.8 billion from the same period of the previous year to ¥32.9 billion, due to higher sales volumes and improved terms of trade, among other factors.」

    In Mobility, higher sales volumes and improved terms of trade lifted operating profit by ¥1.8 billion year on year to ¥32.9 billion.
  30. FY2018-Q2AdvancedAnnual report

    「Operating profit increased by ¥0.9 billion from the same period of the previous year to ¥22.0 billion, due to higher sales volumes and improved terms of trade, among other factors.」

    In Mobility, higher sales volumes lifted operating profit by ¥0.9 billion year on year to ¥22.0 billion.
  31. FY2017AdvancedAnnual report

    「In the Mobility business, functional resin products, centered on polypropylene (PP) compounds and elastomers, contributed to the steady recovery of growth investments made to date, supported by expanding demand accompanying higher automobile sales.」

    For functional resin products in the growth businesses, the company noted their contribution to the recovery of growth investments against a backdrop of expanding demand.
  32. FY2016First statedAnnual report

    「Further expanding earnings in businesses driving growth」

    This was identified as one of the priority issues for fiscal 2016.
Moved together

"Strengthening the Profitability of Existing Businesses" moved the same way as this thread, in the same document, in 7 of its 32 moves.

766654★123456
  1. ★This thread
  2. 1Strengthening the Profitability of Existing Businesses7×
  3. 2Rebuilding the Basic Materials business centered on petrochemicals and basic chemicals6×
  4. 3Earnings recovery through the restructuring of underperforming businesses6×
  5. 4Consolidated Dividend Payout Ratio of at Least 25% and DOE of at Least 2%6×
  6. 5Credit, Foreign Exchange, Interest Rate, and Funding Risks5×
  7. 6Improving and Strengthening the Financial Position4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Mitsui Chemicals's next results are scheduled for 2026-11-11. Read the earnings preview It last moved in the Earnings presentation of 2026-08-05: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.